Ranbaxy Wins FDA Approval Says Sachin Karpe

Ranbaxy, Sachin Karpe

Ranbaxy won approval to produce a long-delayed generic version of Novartis AG NOVN.VX -0.31% ‘s blockbuster blood-pressure drug Diovan says Sachin Karpe. This approval will be prove important in improving company’s prospects after years of regulatory problems. This production was to begin in 2012 but Food and Drug Administration had banned export of this drug to US. Ranbaxy;s New Jersey based subsidiary Ohm Laboratories will make the drug.

Tagged: , ,

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

%d bloggers like this: